Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-01

Clinical Trial Update: Remimazolam Improves the Safety in Elderly Patients Undergoing Gastrointestinal Endoscopy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing remimazolam safety in elderly patients undergoing gastrointestinal endoscopy, focusing on improved safety in this population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remimazolam (remimazolam)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Anesthetics, Recovery | Phase 4 | Status: UNKNOWN